Safety and effectiveness of edoxaban in Japanese patients with nonvalvular atrial fibrillation: Final report of a two‐year postmarketing surveillance study (ETNA‐AF‐Japan)

BACKGROUND: Direct oral anticoagulants (DOACs) are the recommended first‐line therapy for ischemic stroke prevention in patients with nonvalvular atrial fibrillation (NVAF). However, the safety and effectiveness of edoxaban for this indication requires monitoring over the long term in real‐world set...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamashita, Takeshi, Koretsune, Yukihiro, Nagao, Tomoko, Shiosakai, Kazuhito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021991/
https://www.ncbi.nlm.nih.gov/pubmed/33850579
http://dx.doi.org/10.1002/joa3.12520

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021991/
https://www.ncbi.nlm.nih.gov/pubmed/33850579
http://dx.doi.org/10.1002/joa3.12520

Ejemplares similares